185 related articles for article (PubMed ID: 31928509)
1. Prevalence of Metabolic Syndrome Among Patients with Psoriasis Treated with TNF Inhibitors and the Effects of Anti-TNF Therapy on Their Lipid Profile: A Prospective Cohort Study.
Botelho KP; Pontes MAA; Rodrigues CEM; Freitas MVC
Metab Syndr Relat Disord; 2020 Apr; 18(3):154-160. PubMed ID: 31928509
[No Abstract] [Full Text] [Related]
2. Effects of etanercept treatment on lipid profile in patients with moderate-to-severe chronic plaque psoriasis: a retrospective cohort study.
Lestre S; Diamantino F; Veloso L; Fidalgo A; Ferreira A
Eur J Dermatol; 2011; 21(6):916-20. PubMed ID: 21983007
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and psoriasis: a study in 97 patients.
Ferdinando LB; Fukumoto PK; Sanches S; Fabricio LHZ; Skare TL
Rev Assoc Med Bras (1992); 2018 Apr; 64(4):368-373. PubMed ID: 30133617
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents.
Al Mutairi N; Alrqobah D; Haji Hussain N
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29334162
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study.
Waljee AK; Higgins PDR; Jensen CB; Villumsen M; Cohen-Mekelburg SA; Wallace BI; Berinstein JA; Allin KH; Jess T
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):276-284. PubMed ID: 31836320
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis.
Adışen E; Uzun S; Erduran F; Gürer MA
An Bras Dermatol; 2018 Mar; 93(2):205-211. PubMed ID: 29723384
[TBL] [Abstract][Full Text] [Related]
7. The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study.
Campanati A; Molinelli E; Ganzetti G; Giuliodori K; Minetti I; Taus M; Catani M; Martina E; Conocchiari L; Offidani A
J Dermatolog Treat; 2017 May; 28(3):206-212. PubMed ID: 27552000
[TBL] [Abstract][Full Text] [Related]
8. Effects of tumor necrosis factor-alpha inhibitors on lipid profiles in patients with psoriasis: a systematic review and meta-analysis.
Su L; Xu C; Huang H; Zhang P; Wang J; Ouyang X; Yang X; Ye J
Front Immunol; 2024; 15():1354593. PubMed ID: 38500874
[TBL] [Abstract][Full Text] [Related]
9. Rates of latent tuberculosis infection in patients treated with TNF inhibitors for psoriasis: a retrospective chart review.
Lee EB; Amin M; Man J; Egeberg A; Wu JJ
J Dermatolog Treat; 2018 Nov; 29(7):671-675. PubMed ID: 29455561
[TBL] [Abstract][Full Text] [Related]
10. Effects of TNFα inhibitors in patients with psoriasis and metabolic syndrome: a preliminary study.
Merlo G; Cozzani E; Burlando M; Calvieri S; Potenza C; Stingeni L; Filosa G; Pau M; Simonacci M; Caproni M; Parodi A
G Ital Dermatol Venereol; 2020 Feb; 155(1):14-18. PubMed ID: 28421729
[TBL] [Abstract][Full Text] [Related]
11. Anti-TNF- αtreatment-related pathways and biomarkers revealed by transcriptome analysis in Chinese psoriasis patients.
Liu L; Liu W; Zheng Y; Chen J; Zhou J; Dai H; Cai S; Liu J; Zheng M; Ren Y
BMC Syst Biol; 2019 Apr; 13(Suppl 2):29. PubMed ID: 30953507
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
Gisondi P; Cotena C; Tessari G; Girolomoni G
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
[TBL] [Abstract][Full Text] [Related]
13. Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study.
Garcovich S; Ruggeri A; D'Agostino M; Ardito F; De Simone C; Delogu G; Fadda G
J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1572-6. PubMed ID: 21923840
[TBL] [Abstract][Full Text] [Related]
14. Induction of Autoantibodies and Autoimmune Diseases in Patients with Psoriasis Receiving Tumor Necrosis Factor Inhibitors.
Oter-López B; Llamas-Velasco M; Sánchez-Pérez J; Dauden E
Actas Dermosifiliogr; 2017 Jun; 108(5):445-456. PubMed ID: 28267955
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry.
Piaserico S; Cazzaniga S; Chimenti S; Giannetti A; Maccarone M; Picardo M; Peserico A; Naldi L;
J Am Acad Dermatol; 2014 Feb; 70(2):257-62.e3. PubMed ID: 24355410
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010.
Shmidt E; Wetter DA; Ferguson SB; Pittelkow MR
J Am Acad Dermatol; 2012 Nov; 67(5):e179-85. PubMed ID: 21752492
[TBL] [Abstract][Full Text] [Related]
17. Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris.
Gniadecki R; Kragballe K; Dam TN; Skov L
Br J Dermatol; 2011 May; 164(5):1091-6. PubMed ID: 21219290
[TBL] [Abstract][Full Text] [Related]
18. Determination of adalimumab and etanercept trough levels and drug antibodies in long-term psoriasis treatment: a single-centre cohort study.
Manriquez J; Alsina-Gibert M
Clin Exp Dermatol; 2017 Jan; 42(1):14-20. PubMed ID: 27943384
[TBL] [Abstract][Full Text] [Related]
19. Association Between Pediatric Psoriasis and Waist-to-Height Ratio in the Absence of Obesity: A Multicenter Australian Study.
Lee A; Smith SD; Hong E; Garnett S; Fischer G
JAMA Dermatol; 2016 Dec; 152(12):1314-1319. PubMed ID: 27681388
[TBL] [Abstract][Full Text] [Related]
20. Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study.
Esposito M; Gisondi P; Cassano N; Ferrucci G; Del Giglio M; Loconsole F; Giunta A; Vena GA; Chimenti S; Girolomoni G
Br J Dermatol; 2013 Sep; 169(3):666-72. PubMed ID: 23647206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]